Inhibrx Biosciences (INBX) Net Margin (2023 - 2025)
Historic Net Margin for Inhibrx Biosciences (INBX) over the last 3 years, with Q2 2025 value amounting to 2204.15%.
- Inhibrx Biosciences' Net Margin fell 18602151500.0% to 2204.15% in Q2 2025 from the same period last year, while for Sep 2025 it was 12031.5%, marking a year-over-year increase of 377267300.0%. This contributed to the annual value of 843786.0% for FY2024, which is 8571041700.0% up from last year.
- Inhibrx Biosciences' Net Margin amounted to 2204.15% in Q2 2025, which was down 18602151500.0% from 1610.67% recorded in Q1 2025.
- In the past 5 years, Inhibrx Biosciences' Net Margin ranged from a high of 1858011.0% in Q2 2024 and a low of 156840.0% during Q2 2023
- Its 3-year average for Net Margin is 200566.5%, with a median of 3916.34% in 2025.
- Per our database at Business Quant, Inhibrx Biosciences' Net Margin soared by 2000000000bps in 2024 and then plummeted by 2000000000bps in 2025.
- Quarter analysis of 3 years shows Inhibrx Biosciences' Net Margin stood at 5628.52% in 2023, then crashed by -750bps to 47865.0% in 2024, then soared by 95bps to 2204.15% in 2025.
- Its Net Margin stands at 2204.15% for Q2 2025, versus 1610.67% for Q1 2025 and 47865.0% for Q4 2024.